Author:
Gordon Paul,Emerson Hannah M.,Dickerson Faith,Patel Surbhi B.,Riebe Genevieve
Reference79 articles.
1. Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess. 2007;154:1–122.
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.
3. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005;16(3):346–54.
4. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gy. 2017;124(10):1501–12.
5. Food US, Administration D. FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids. FDA safety communication. USFDA: Silver Spring; 2017.